In the last 12 months, insiders at Atea Pharmaceuticals, Inc. ($AVIR) filed 177 transactions with the SEC: 4 open-market purchases totaling $162,997 and 12 sales totaling $1,810,733. Net insider sentiment: net selling.
Atea Pharmaceuticals, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Sommadossi Jean-Pierre (President, CEO, and Chairman) — 22 transactions totaling $1,549,951
- BERGER FRANKLIN M (Not found) — 13 transactions totaling $1,186,472
- Corcoran Andrea (See Remarks) — 19 transactions totaling $252,868
- Horga Maria Arantxa (Chief Medical Officer) — 17 transactions totaling $178,290
- Hammond Janet MJ (Chief Development Officer) — 17 transactions totaling $157,100
View all SEC Filings for Atea Pharmaceuticals, Inc. (AVIR).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 11, 2026 | Corcoran Andrea | See Remarks | M | Stock Option (Right to Buy) | 60000 | $0.00 | 0.0000 | 78,126,796 | 0.00% | 0.08% |
| March 11, 2026 | Corcoran Andrea | See Remarks | M | Common Stock | 60000 | $1.24 | 823,576.0000 | 78,126,796 | 7.86% | 0.08% |
| Jan. 31, 2026 | Vavricka John | Chief Commercial Officer | M | Restricted Stock Units | 8750 | $0.00 | 0.0000 | 78,126,796 | 100.00% | 0.01% |
| Jan. 31, 2026 | Vavricka John | Chief Commercial Officer | A | Stock Option (Right to Buy) | 119520 | $0.00 | 119,520.0000 | 78,126,796 | 9999.99% | 0.15% |
| Jan. 31, 2026 | Hammond Janet MJ | Chief Development Officer | M | Common Stock | 58050 | $0.00 | 141,801.0000 | 78,126,796 | 69.31% | 0.07% |
| Jan. 31, 2026 | Hammond Janet MJ | Chief Development Officer | F | Common Stock | 14136 | $4.24 | 127,665.0000 | 78,126,796 | 9.97% | 0.02% |
| Jan. 31, 2026 | Hammond Janet MJ | Chief Development Officer | M | Restricted Stock Units | 46800 | $0.00 | 0.0000 | 78,126,796 | 100.00% | 0.06% |
| Jan. 31, 2026 | Hammond Janet MJ | Chief Development Officer | M | Restricted Stock Units | 11250 | $0.00 | 0.0000 | 78,126,796 | 100.00% | 0.01% |
| Jan. 31, 2026 | Hammond Janet MJ | Chief Development Officer | A | Stock Option (Right to Buy) | 177000 | $0.00 | 177,000.0000 | 78,126,796 | 9999.99% | 0.23% |
| Jan. 31, 2026 | Corcoran Andrea | See Remarks | M | Common Stock | 54866 | $0.00 | 779,680.0000 | 78,126,796 | 7.57% | 0.07% |
| Jan. 31, 2026 | Corcoran Andrea | See Remarks | F | Common Stock | 16104 | $4.24 | 763,576.0000 | 78,126,796 | 2.07% | 0.02% |
| Jan. 31, 2026 | Corcoran Andrea | See Remarks | M | Restricted Stock Units | 44366 | $0.00 | 0.0000 | 78,126,796 | 100.00% | 0.06% |
| Jan. 31, 2026 | Corcoran Andrea | See Remarks | M | Restricted Stock Units | 10500 | $0.00 | 0.0000 | 78,126,796 | 100.00% | 0.01% |
| Jan. 31, 2026 | Corcoran Andrea | See Remarks | A | Stock Option (Right to Buy) | 180000 | $0.00 | 180,000.0000 | 78,126,796 | 9999.99% | 0.23% |
| Jan. 31, 2026 | Sommadossi Jean-Pierre | President, CEO, and Chairman | M | Common Stock | 272983 | $0.00 | 6,439,948.0000 | 78,126,796 | 4.43% | 0.35% |
| Jan. 31, 2026 | Sommadossi Jean-Pierre | President, CEO, and Chairman | F | Common Stock | 106093 | $4.24 | 6,333,855.0000 | 78,126,796 | 1.65% | 0.14% |
| Feb. 3, 2026 | Sommadossi Jean-Pierre | President, CEO, and Chairman | M | Common Stock | 300000 | $1.24 | 6,633,855.0000 | 78,126,796 | 4.74% | 0.38% |
| Jan. 31, 2026 | Sommadossi Jean-Pierre | President, CEO, and Chairman | M | Restricted Stock Units | 173466 | $0.00 | 0.0000 | 78,126,796 | 100.00% | 0.22% |
| Jan. 31, 2026 | Sommadossi Jean-Pierre | President, CEO, and Chairman | M | Restricted Stock Units | 99517 | $0.00 | 0.0000 | 78,126,796 | 100.00% | 0.13% |
| Feb. 3, 2026 | Sommadossi Jean-Pierre | President, CEO, and Chairman | M | Stock Option (Right to Buy) | 300000 | $0.00 | 0.0000 | 78,126,796 | 100.00% | 0.38% |
| Jan. 31, 2026 | Foster Wayne | EVP, Chief Accounting Officer | M | Restricted Stock Units | 33333 | $0.00 | 0.0000 | 78,126,796 | 100.00% | 0.04% |
| Jan. 31, 2026 | Foster Wayne | EVP, Chief Accounting Officer | M | Common Stock | 41333 | $0.00 | 91,461.0000 | 78,126,796 | 82.45% | 0.05% |
| Jan. 31, 2026 | Foster Wayne | EVP, Chief Accounting Officer | F | Common Stock | 12132 | $4.24 | 79,329.0000 | 78,126,796 | 13.26% | 0.02% |
| Jan. 31, 2026 | Foster Wayne | EVP, Chief Accounting Officer | M | Restricted Stock Units | 8000 | $0.00 | 0.0000 | 78,126,796 | 100.00% | 0.01% |
| Jan. 31, 2026 | Foster Wayne | EVP, Chief Accounting Officer | A | Stock Option (Right to Buy) | 108000 | $0.00 | 108,000.0000 | 78,126,796 | 9999.99% | 0.14% |
| Jan. 31, 2026 | Horga Maria Arantxa | Chief Medical Officer | M | Common Stock | 51283 | $0.00 | 112,159.0000 | 78,126,796 | 84.24% | 0.07% |
| Jan. 31, 2026 | Horga Maria Arantxa | Chief Medical Officer | F | Common Stock | 16073 | $4.24 | 96,086.0000 | 78,126,796 | 14.33% | 0.02% |
| Jan. 31, 2026 | Horga Maria Arantxa | Chief Medical Officer | M | Restricted Stock Units | 41533 | $0.00 | 0.0000 | 78,126,796 | 100.00% | 0.05% |
| Jan. 31, 2026 | Horga Maria Arantxa | Chief Medical Officer | M | Restricted Stock Units | 9750 | $0.00 | 0.0000 | 78,126,796 | 100.00% | 0.01% |
| Jan. 31, 2026 | Horga Maria Arantxa | Chief Medical Officer | A | Stock Option (Right to Buy) | 173500 | $0.00 | 173,500.0000 | 78,126,796 | 9999.99% | 0.22% |
| Jan. 31, 2026 | Vavricka John | Chief Commercial Officer | F | Common Stock | 11570 | $4.24 | 165,102.0000 | 78,126,796 | 6.55% | 0.01% |
| Jan. 31, 2026 | Vavricka John | Chief Commercial Officer | M | Common Stock | 42083 | $0.00 | 176,672.0000 | 78,126,796 | 31.27% | 0.05% |
| Jan. 31, 2026 | Vavricka John | Chief Commercial Officer | M | Restricted Stock Units | 33333 | $0.00 | 0.0000 | 78,126,796 | 100.00% | 0.04% |
| June 20, 2025 | Lucidi Bruno | Not found | A | Stock Option (Right to Buy) | 41200 | $0.00 | 41,200.0000 | 85,525,179 | 9999.99% | 0.05% |
| June 20, 2025 | Murphy Polly A. | Not found | M | Restricted Stock Units | 29600 | $0.00 | 0.0000 | 85,525,179 | 100.00% | 0.03% |
| June 20, 2025 | Duncan Barbara Gayle | Not found | M | Common Stock | 29600 | $0.00 | 62,750.0000 | 85,525,179 | 89.29% | 0.03% |
| June 20, 2025 | Duncan Barbara Gayle | Not found | A | Restricted Stock Units | 29600 | $0.00 | 29,600.0000 | 85,525,179 | 9999.99% | 0.03% |
| June 20, 2025 | Duncan Barbara Gayle | Not found | A | Stock Option (Right to Buy) | 41200 | $0.00 | 41,200.0000 | 85,525,179 | 9999.99% | 0.05% |
| June 20, 2025 | Duncan Barbara Gayle | Not found | M | Restricted Stock Units | 29600 | $0.00 | 0.0000 | 85,525,179 | 100.00% | 0.03% |
| June 20, 2025 | BERGER FRANKLIN M | Not found | M | Common Stock | 29600 | $0.00 | 506,497.0000 | 85,525,179 | 6.21% | 0.03% |
| June 20, 2025 | BERGER FRANKLIN M | Not found | A | Restricted Stock Units | 29600 | $0.00 | 29,600.0000 | 85,525,179 | 9999.99% | 0.03% |
| June 20, 2025 | BERGER FRANKLIN M | Not found | A | Stock Option (Right to Buy) | 41200 | $0.00 | 41,200.0000 | 85,525,179 | 9999.99% | 0.05% |
| June 20, 2025 | BERGER FRANKLIN M | Not found | M | Restricted Stock Units | 29600 | $0.00 | 0.0000 | 85,525,179 | 100.00% | 0.03% |
| June 20, 2025 | Polsky Bruce | Not found | M | Common Stock | 29600 | $0.00 | 95,206.0000 | 85,525,179 | 45.12% | 0.03% |
| June 20, 2025 | Polsky Bruce | Not found | A | Restricted Stock Units | 29600 | $0.00 | 29,600.0000 | 85,525,179 | 9999.99% | 0.03% |
| June 20, 2025 | Polsky Bruce | Not found | A | Stock Option (Right to Buy) | 41200 | $0.00 | 41,200.0000 | 85,525,179 | 9999.99% | 0.05% |
| June 20, 2025 | Polsky Bruce | Not found | M | Restricted Stock Units | 29600 | $0.00 | 0.0000 | 85,525,179 | 100.00% | 0.03% |
| June 20, 2025 | Adams Jerome M. | Not found | M | Common Stock | 29600 | $0.00 | 62,750.0000 | 85,525,179 | 89.29% | 0.03% |
| June 20, 2025 | Adams Jerome M. | Not found | A | Restricted Stock Units | 29600 | $0.00 | 29,600.0000 | 85,525,179 | 9999.99% | 0.03% |
| June 20, 2025 | Adams Jerome M. | Not found | A | Stock Option (Right to Buy) | 41200 | $0.00 | 41,200.0000 | 85,525,179 | 9999.99% | 0.05% |
| June 20, 2025 | Adams Jerome M. | Not found | M | Restricted Stock Units | 29600 | $0.00 | 0.0000 | 85,525,179 | 100.00% | 0.03% |
| June 20, 2025 | Lucidi Bruno | Not found | M | Common Stock | 29600 | $0.00 | 112,750.0000 | 85,525,179 | 35.60% | 0.03% |
| June 20, 2025 | Lucidi Bruno | Not found | A | Restricted Stock Units | 29600 | $0.00 | 29,600.0000 | 85,525,179 | 9999.99% | 0.03% |
| June 20, 2025 | Lucidi Bruno | Not found | M | Restricted Stock Units | 29600 | $0.00 | 0.0000 | 85,525,179 | 100.00% | 0.03% |
| June 20, 2025 | Berman Howard | Not found | A | Stock Option (Right to Buy) | 164800 | $0.00 | 164,800.0000 | 85,525,179 | 9999.99% | 0.19% |
| June 20, 2025 | Murphy Polly A. | Not found | M | Common Stock | 29600 | $0.00 | 86,045.0000 | 85,525,179 | 52.44% | 0.03% |
| June 20, 2025 | Murphy Polly A. | Not found | A | Restricted Stock Units | 29600 | $0.00 | 29,600.0000 | 85,525,179 | 9999.99% | 0.03% |
| June 20, 2025 | Murphy Polly A. | Not found | A | Stock Option (Right to Buy) | 41200 | $0.00 | 41,200.0000 | 85,525,179 | 9999.99% | 0.05% |
| Feb. 20, 2025 | Kirsch Arthur S | Not found | A | Stock Option (Right to Buy) | 164800 | $0.00 | 164,800.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2025 | Foster Wayne | EVP, Chief Accounting Officer | M | Restricted Stock Units | 33333 | $0.00 | 33,333.0000 | 0 | 50.00% | 0.00% |
| Jan. 31, 2025 | Foster Wayne | EVP, Chief Accounting Officer | A | Restricted Stock Units | 8000 | $0.00 | 8,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2025 | Foster Wayne | EVP, Chief Accounting Officer | A | Stock Option (Right to Buy) | 120100 | $0.00 | 120,100.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2025 | Hammond Janet MJ | Chief Development Officer | A | Common Stock | 11250 | $0.00 | 95,522.0000 | 0 | 13.35% | 0.00% |
| Jan. 31, 2025 | Sommadossi Jean-Pierre | President, CEO, and Chairman | A | Restricted Stock Units | 99518 | $0.00 | 99,518.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2025 | Sommadossi Jean-Pierre | President, CEO, and Chairman | M | Restricted Stock Units | 173467 | $0.00 | 173,466.0000 | 0 | 50.00% | 0.00% |
| Jan. 31, 2025 | Sommadossi Jean-Pierre | President, CEO, and Chairman | F | Common Stock | 88601 | $3.06 | 6,166,965.0000 | 0 | 1.42% | 0.00% |
| Jan. 31, 2025 | Sommadossi Jean-Pierre | President, CEO, and Chairman | A | Common Stock | 99517 | $0.00 | 6,255,566.0000 | 0 | 1.62% | 0.00% |
| Jan. 31, 2025 | Sommadossi Jean-Pierre | President, CEO, and Chairman | M | Common Stock | 173467 | $0.00 | 6,156,049.0000 | 0 | 2.90% | 0.00% |
| Jan. 31, 2025 | Corcoran Andrea | See Remarks | A | Stock Option (Right to Buy) | 200000 | $0.00 | 200,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2025 | Corcoran Andrea | See Remarks | A | Restricted Stock Units | 10500 | $0.00 | 10,500.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2025 | Corcoran Andrea | See Remarks | M | Restricted Stock Units | 44367 | $0.00 | 44,366.0000 | 0 | 50.00% | 0.00% |
| Jan. 31, 2025 | Corcoran Andrea | See Remarks | F | Common Stock | 16102 | $3.06 | 717,307.0000 | 0 | 2.20% | 0.00% |
| Jan. 31, 2025 | Corcoran Andrea | See Remarks | A | Common Stock | 10500 | $0.00 | 733,409.0000 | 0 | 1.45% | 0.00% |
| Jan. 31, 2025 | Corcoran Andrea | See Remarks | M | Common Stock | 44367 | $0.00 | 722,909.0000 | 0 | 6.54% | 0.00% |
| Jan. 31, 2025 | Horga Maria Arantxa | Chief Medical Officer | A | Stock Option (Right to Buy) | 192800 | $0.00 | 192,800.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2025 | Horga Maria Arantxa | Chief Medical Officer | A | Restricted Stock Units | 9750 | $0.00 | 9,750.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2025 | Horga Maria Arantxa | Chief Medical Officer | M | Restricted Stock Units | 41533 | $0.00 | 41,533.0000 | 0 | 50.00% | 0.00% |
| Jan. 31, 2025 | Horga Maria Arantxa | Chief Medical Officer | F | Common Stock | 16071 | $3.06 | 60,876.0000 | 0 | 20.89% | 0.00% |
| Jan. 31, 2025 | Horga Maria Arantxa | Chief Medical Officer | A | Common Stock | 9750 | $0.00 | 76,947.0000 | 0 | 14.51% | 0.00% |
| Jan. 31, 2025 | Horga Maria Arantxa | Chief Medical Officer | M | Common Stock | 41533 | $0.00 | 67,197.0000 | 0 | 161.83% | 0.00% |
| Jan. 31, 2025 | Vavricka John | Chief Commercial Officer | A | Stock Option (Right to Buy) | 132800 | $0.00 | 132,800.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2025 | Hammond Janet MJ | Chief Development Officer | M | Common Stock | 46800 | $0.00 | 84,272.0000 | 0 | 124.89% | 0.00% |
| Jan. 31, 2025 | Vavricka John | Chief Commercial Officer | A | Restricted Stock Units | 8750 | $0.00 | 8,750.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2025 | Vavricka John | Chief Commercial Officer | M | Restricted Stock Units | 33333 | $0.00 | 33,333.0000 | 0 | 50.00% | 0.00% |
| Jan. 31, 2025 | Vavricka John | Chief Commercial Officer | F | Common Stock | 11517 | $3.06 | 134,589.0000 | 0 | 7.88% | 0.00% |
| Jan. 31, 2025 | Vavricka John | Chief Commercial Officer | A | Common Stock | 8750 | $0.00 | 146,106.0000 | 0 | 6.37% | 0.00% |
| Jan. 31, 2025 | Vavricka John | Chief Commercial Officer | M | Common Stock | 33333 | $0.00 | 137,356.0000 | 0 | 32.04% | 0.00% |
| Jan. 31, 2025 | Hammond Janet MJ | Chief Development Officer | A | Stock Option (Right to Buy) | 200000 | $0.00 | 200,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2025 | Hammond Janet MJ | Chief Development Officer | A | Restricted Stock Units | 11250 | $0.00 | 11,250.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2025 | Hammond Janet MJ | Chief Development Officer | M | Restricted Stock Units | 46800 | $0.00 | 46,800.0000 | 0 | 50.00% | 0.00% |
| Jan. 31, 2025 | Hammond Janet MJ | Chief Development Officer | F | Common Stock | 14134 | $3.06 | 81,388.0000 | 0 | 14.80% | 0.00% |
| Jan. 31, 2025 | Sommadossi Jean-Pierre | President, CEO, and Chairman | A | Stock Option (Right to Buy) | 440000 | $0.00 | 440,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2025 | Foster Wayne | EVP, Chief Accounting Officer | M | Common Stock | 33333 | $0.00 | 54,190.0000 | 0 | 159.82% | 0.00% |
| Jan. 31, 2025 | Foster Wayne | EVP, Chief Accounting Officer | F | Common Stock | 12062 | $3.06 | 50,128.0000 | 0 | 19.40% | 0.00% |
| Jan. 31, 2025 | Foster Wayne | EVP, Chief Accounting Officer | A | Common Stock | 8000 | $0.00 | 62,190.0000 | 0 | 14.76% | 0.00% |
| Jan. 16, 2025 | BERGER FRANKLIN M | Not found | P | Common Stock | 10000 | $3.36 | 476,897.0000 | 0 | 2.05% | 0.00% |
| Jan. 15, 2025 | BERGER FRANKLIN M | Not found | P | Common Stock | 15000 | $3.19 | 466,897.0000 | 0 | 3.32% | 0.00% |
| Jan. 16, 2025 | BERGER FRANKLIN M | Not found | P | Common Stock | 10000 | $3.36 | 476,897.0000 | 0 | 2.14% | 0.00% |
| Jan. 15, 2025 | BERGER FRANKLIN M | Not found | P | Common Stock | 15000 | $3.19 | 466,897.0000 | 0 | 3.11% | 0.00% |
| Dec. 10, 2024 | BERGER FRANKLIN M | Not found | S | Common Stock | 359606 | $2.85 | 451,897.0000 | 0 | 44.31% | 0.00% |
| Sept. 19, 2024 | Sommadossi Jean-Pierre | President, CEO, and Chairman | S | Common Stock | 1841 | $4.00 | 5,982,582.0000 | 0 | 0.03% | 0.00% |
| Sept. 18, 2024 | Sommadossi Jean-Pierre | President, CEO, and Chairman | S | Common Stock | 22187 | $4.03 | 5,984,423.0000 | 0 | 0.37% | 0.00% |
| Sept. 17, 2024 | Sommadossi Jean-Pierre | President, CEO, and Chairman | S | Common Stock | 33941 | $4.05 | 6,006,610.0000 | 0 | 0.56% | 0.00% |
| June 21, 2024 | Murphy Polly A. | Not found | A | Restricted Stock Units | 29600 | $0.00 | 29,600.0000 | 0 | 9999.99% | 0.00% |
| June 21, 2024 | Murphy Polly A. | Not found | A | Stock Option (Right to Buy) | 41200 | $0.00 | 41,200.0000 | 0 | 9999.99% | 0.00% |
| June 21, 2024 | Lucidi Bruno | Not found | A | Restricted Stock Units | 29600 | $0.00 | 29,600.0000 | 0 | 9999.99% | 0.00% |
| June 20, 2024 | Polsky Bruce | Not found | S | Common Stock | 17544 | $3.49 | 65,606.0000 | 0 | 21.10% | 0.00% |
| June 21, 2024 | Polsky Bruce | Not found | A | Restricted Stock Units | 29600 | $0.00 | 29,600.0000 | 0 | 9999.99% | 0.00% |
| June 21, 2024 | Polsky Bruce | Not found | A | Stock Option (Right to Buy) | 41200 | $0.00 | 41,200.0000 | 0 | 9999.99% | 0.00% |
| June 21, 2024 | Duncan Barbara Gayle | Not found | A | Restricted Stock Units | 29600 | $0.00 | 29,600.0000 | 0 | 9999.99% | 0.00% |
| June 21, 2024 | Duncan Barbara Gayle | Not found | A | Stock Option (Right to Buy) | 41200 | $0.00 | 41,200.0000 | 0 | 9999.99% | 0.00% |
| June 21, 2024 | BERGER FRANKLIN M | Not found | A | Restricted Stock Units | 29600 | $0.00 | 29,600.0000 | 0 | 9999.99% | 0.00% |
| June 21, 2024 | BERGER FRANKLIN M | Not found | A | Stock Option (Right to Buy) | 41200 | $0.00 | 41,200.0000 | 0 | 9999.99% | 0.00% |
| June 21, 2024 | Adams Jerome M. | Not found | A | Restricted Stock Units | 29600 | $0.00 | 29,600.0000 | 0 | 9999.99% | 0.00% |
| June 21, 2024 | Adams Jerome M. | Not found | A | Stock Option (Right to Buy) | 41200 | $0.00 | 41,200.0000 | 0 | 9999.99% | 0.00% |
| June 21, 2024 | Lucidi Bruno | Not found | A | Stock Option (Right to Buy) | 41200 | $0.00 | 41,200.0000 | 0 | 9999.99% | 0.00% |
| June 16, 2024 | Murphy Polly A. | Not found | M | Common Stock | 33150 | $0.00 | 56,445.0000 | 0 | 142.31% | 0.00% |
| June 16, 2024 | Adams Jerome M. | Not found | M | Restricted Stock Units | 33150 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 16, 2024 | Adams Jerome M. | Not found | M | Common Stock | 33150 | $0.00 | 33,150.0000 | 0 | 9999.99% | 0.00% |
| June 16, 2024 | Duncan Barbara Gayle | Not found | M | Restricted Stock Units | 33150 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 16, 2024 | Duncan Barbara Gayle | Not found | M | Common Stock | 33150 | $0.00 | 33,150.0000 | 0 | 9999.99% | 0.00% |
| June 16, 2024 | Polsky Bruce | Not found | M | Restricted Stock Units | 33150 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 16, 2024 | BERGER FRANKLIN M | Not found | M | Common Stock | 33150 | $0.00 | 811,503.0000 | 0 | 4.26% | 0.00% |
| June 16, 2024 | BERGER FRANKLIN M | Not found | M | Restricted Stock Units | 33150 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 16, 2024 | Polsky Bruce | Not found | M | Common Stock | 33150 | $0.00 | 83,150.0000 | 0 | 66.30% | 0.00% |
| June 16, 2024 | Lucidi Bruno | Not found | M | Restricted Stock Units | 33150 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 16, 2024 | Lucidi Bruno | Not found | M | Common Stock | 33150 | $0.00 | 83,150.0000 | 0 | 66.30% | 0.00% |
| June 16, 2024 | Murphy Polly A. | Not found | M | Restricted Stock Units | 33150 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 5, 2024 | Sommadossi Jean-Pierre | President, CEO, and Chairman | S | Common Stock | 1006 | $4.00 | 6,040,551.0000 | 0 | 0.02% | 0.00% |
| Jan. 31, 2024 | Hammond Janet MJ | Chief Development Officer | A | Stock Option (Right to Buy) | 225200 | $0.00 | 225,200.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2024 | Sommadossi Jean-Pierre | President, CEO, and Chairman | M | Restricted Stock Units | 173467 | $0.00 | 346,933.0000 | 0 | 33.33% | 0.00% |
| Jan. 31, 2024 | Sommadossi Jean-Pierre | President, CEO, and Chairman | A | Stock Option (Right to Buy) | 448000 | $0.00 | 448,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2024 | Horga Maria Arantxa | Chief Medical Officer | M | Common Stock | 41534 | $0.00 | 41,534.0000 | 0 | 9999.99% | 0.00% |
| Feb. 1, 2024 | Horga Maria Arantxa | Chief Medical Officer | S | Common Stock | 15870 | $3.84 | 25,664.0000 | 0 | 38.21% | 0.00% |
| Jan. 31, 2024 | Horga Maria Arantxa | Chief Medical Officer | M | Restricted Stock Units | 41534 | $0.00 | 83,066.0000 | 0 | 33.33% | 0.00% |
| Jan. 31, 2024 | Horga Maria Arantxa | Chief Medical Officer | A | Stock Option (Right to Buy) | 192800 | $0.00 | 192,800.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2024 | Foster Wayne | EVP, Chief Accounting Officer | M | Common Stock | 33334 | $0.00 | 33,334.0000 | 0 | 9999.99% | 0.00% |
| Feb. 1, 2024 | Foster Wayne | EVP, Chief Accounting Officer | S | Common Stock | 12477 | $3.84 | 20,857.0000 | 0 | 37.43% | 0.00% |
| Jan. 31, 2024 | Foster Wayne | EVP, Chief Accounting Officer | M | Restricted Stock Units | 33334 | $0.00 | 66,666.0000 | 0 | 33.33% | 0.00% |
| Jan. 31, 2024 | Foster Wayne | EVP, Chief Accounting Officer | A | Stock Option (Right to Buy) | 120100 | $0.00 | 120,100.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2024 | Vavricka John | Chief Commercial Officer | M | Common Stock | 33334 | $0.00 | 115,842.0000 | 0 | 40.40% | 0.00% |
| Feb. 1, 2024 | Vavricka John | Chief Commercial Officer | S | Common Stock | 11819 | $3.84 | 104,023.0000 | 0 | 10.20% | 0.00% |
| Jan. 31, 2024 | Vavricka John | Chief Commercial Officer | M | Restricted Stock Units | 33334 | $0.00 | 66,666.0000 | 0 | 33.33% | 0.00% |
| Jan. 31, 2024 | Vavricka John | Chief Commercial Officer | A | Stock Option (Right to Buy) | 132800 | $0.00 | 132,800.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2024 | Hammond Janet MJ | Chief Development Officer | M | Common Stock | 46800 | $0.00 | 49,391.0000 | 0 | 1806.25% | 0.00% |
| Feb. 1, 2024 | Hammond Janet MJ | Chief Development Officer | S | Common Stock | 14029 | $3.84 | 35,362.0000 | 0 | 28.40% | 0.00% |
| Jan. 31, 2024 | Hammond Janet MJ | Chief Development Officer | M | Restricted Stock Units | 46800 | $0.00 | 93,600.0000 | 0 | 33.33% | 0.00% |
| Feb. 1, 2024 | Sommadossi Jean-Pierre | President, CEO, and Chairman | S | Common Stock | 56910 | $3.85 | 6,041,557.0000 | 0 | 0.93% | 0.00% |
| Jan. 31, 2024 | Corcoran Andrea | See Remarks | A | Stock Option (Right to Buy) | 200000 | $0.00 | 200,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2024 | Corcoran Andrea | See Remarks | M | Restricted Stock Units | 44367 | $0.00 | 88,733.0000 | 0 | 33.33% | 0.00% |
| Feb. 1, 2024 | Corcoran Andrea | See Remarks | S | Common Stock | 15843 | $3.84 | 670,208.0000 | 0 | 2.31% | 0.00% |
| Jan. 31, 2024 | Corcoran Andrea | See Remarks | M | Common Stock | 44367 | $0.00 | 686,051.0000 | 0 | 6.91% | 0.00% |
| Jan. 31, 2024 | Sommadossi Jean-Pierre | President, CEO, and Chairman | M | Common Stock | 173467 | $0.00 | 6,098,467.0000 | 0 | 2.93% | 0.00% |
| June 16, 2023 | Duncan Barbara Gayle | Director | A | Restricted Stock Units | 33150 | $0.00 | 33,150.0000 | 0 | 9999.99% | 0.00% |
| June 16, 2023 | Adams Jerome M. | Director | A | Stock Option (Right to Buy) | 46750 | $0.00 | 46,750.0000 | 0 | 9999.99% | 0.00% |
| June 16, 2023 | Adams Jerome M. | Director | A | Restricted Stock Units | 33150 | $0.00 | 33,150.0000 | 0 | 9999.99% | 0.00% |
| June 16, 2023 | Lucidi Bruno | Director | A | Stock Option (Right to Buy) | 46750 | $0.00 | 46,750.0000 | 0 | 9999.99% | 0.00% |
| June 16, 2023 | Lucidi Bruno | Director | A | Restricted Stock Units | 33150 | $0.00 | 33,150.0000 | 0 | 9999.99% | 0.00% |
| June 16, 2023 | BERGER FRANKLIN M | Director | A | Stock Option (Right to Buy) | 46750 | $0.00 | 46,750.0000 | 0 | 9999.99% | 0.00% |
| June 16, 2023 | BERGER FRANKLIN M | Director | A | Restricted Stock Units | 33150 | $0.00 | 33,150.0000 | 0 | 9999.99% | 0.00% |
| June 16, 2023 | Polsky Bruce | Director | A | Stock Option (Right to Buy) | 46750 | $0.00 | 46,750.0000 | 0 | 9999.99% | 0.00% |
| June 16, 2023 | Polsky Bruce | Director | A | Restricted Stock Units | 33150 | $0.00 | 33,150.0000 | 0 | 9999.99% | 0.00% |
| June 16, 2023 | Murphy Polly A. | Director | A | Stock Option (Right to Buy) | 46750 | $0.00 | 46,750.0000 | 0 | 9999.99% | 0.00% |
| June 16, 2023 | Murphy Polly A. | Director | A | Restricted Stock Units | 33150 | $0.00 | 33,150.0000 | 0 | 9999.99% | 0.00% |
| June 16, 2023 | Duncan Barbara Gayle | Director | A | Stock Option (Right to Buy) | 46750 | $0.00 | 46,750.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2023 | Vavricka John | Chief Commercial Officer | A | Stock Option (Right to Buy) | 140000 | $0.00 | 140,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2023 | Hammond Janet MJ | Chief Development Officer | A | Stock Option (Right to Buy) | 196600 | $0.00 | 196,600.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2023 | Hammond Janet MJ | Chief Development Officer | A | Restricted Stock Units | 140400 | $0.00 | 140,400.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2023 | Corcoran Andrea | See Remarks | A | Stock Option (Right to Buy) | 186300 | $0.00 | 186,300.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2023 | Corcoran Andrea | See Remarks | A | Restricted Stock Units | 133100 | $0.00 | 133,100.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2023 | Sommadossi Jean-Pierre | President, CEO, and Chairman | A | Stock Option (Right to Buy) | 728600 | $0.00 | 728,600.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2023 | Sommadossi Jean-Pierre | President, CEO, and Chairman | A | Restricted Stock Units | 520400 | $0.00 | 520,400.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2023 | Horga Maria Arantxa | Chief Medical Officer | A | Stock Option (Right to Buy) | 174500 | $0.00 | 174,500.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2023 | Horga Maria Arantxa | Chief Medical Officer | A | Restricted Stock Units | 124600 | $0.00 | 124,600.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2023 | Foster Wayne | EVP, Chief Accounting Officer | A | Stock Option (Right to Buy) | 140000 | $0.00 | 140,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2023 | Foster Wayne | EVP, Chief Accounting Officer | A | Restricted Stock Units | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2023 | Vavricka John | Chief Commercial Officer | A | Restricted Stock Units | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |